US Patent 7718198 Treatment modalities for autoimmune diseases
Patent 7718198 was granted and assigned to Metaproteomics on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+321 characters)
Article
Patent abstract
Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Amy Hall0
Anu Desai0
Jeffrey S. Bland0
Matthew Tripp0
Robert Lerman0
Veera Konda0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718198 Treatment modalities for autoimmune diseases US Patent 7718198 Treatment modalities for autoimmune diseases
Infobox
Patent Number
077181980
Patent Number
77181980
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077181980
Date of Patent
May 18, 2010
0Patent Application Number
113268740
Date Filed
January 6, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07718198 Treatment modalities for autoimmune diseases
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07718198
Date of patent
May 18, 2010
Patent application number
11326874
Date Filed
January 6, 2006
Patent primary examiner
Find more entities like US Patent 7718198 Treatment modalities for autoimmune diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
